Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $2.35 Analyst target: $10.00 Upside: 324.63%
Meridian Bioscience, Inc., a life sciences company, develops, manufactures, distributes and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases and elevated blood lead levels worldwide. The company is headquartered in Cincinnati, Ohio.
See the full interactive analysis & chart →Informational only — not investment advice.